Clinical Trial: Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency
Brief Summary: This study is conducted in Europe. The aim of this study is to investigate the self-reported impact of Vagifem® (estradiol) treatment on urogenital discomfort in women with atrophic vaginitis due to oestrogen deficiency.
Detailed Summary:
Sponsor: Novo Nordisk A/S
Current Primary Outcome:
- Percentage of subjects reporting vaginal symptoms occuring 'often' and 'frequently'
- Percentage of subjects reporting 'moderate' and 'severe' vaginal symptoms
Original Primary Outcome: Same as current
Current Secondary Outcome: Adverse events
Original Secondary Outcome: Same as current
Information By: Novo Nordisk A/S
Dates:
Date Received: January 5, 2012
Date Started: April 2006
Date Completion:
Last Updated: February 6, 2017
Last Verified: February 2017